IP Verse

Fatty Acids And Their Use In Conjugation To Biomolecules - EP3157571

The patent EP3157571 was granted to Novartis on Nov 24, 2021. The application was originally filed on Jun 18, 2015 under application number EP15732508A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3157571

NOVARTIS
Application Number
EP15732508A
Filing Date
Jun 18, 2015
Status
Granted And Under Opposition
Oct 22, 2021
Grant Date
Nov 24, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DR H ULRICH DORRIESAug 24, 2022DORRIESADMISSIBLE
DR H ULRICH DORRIESAug 24, 2022DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMANADMISSIBLE

Patent Citations (44) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2004062718
DESCRIPTIONUS2004096403
DESCRIPTIONUS2009068738
DESCRIPTIONUS2011044905
DESCRIPTIONUS2011044977
DESCRIPTIONUS2015017192
DESCRIPTIONUS6492324
DESCRIPTIONUS7083970
DESCRIPTIONUS8465739
DESCRIPTIONUS8476239
DESCRIPTIONUS8673848
DESCRIPTIONWO03043985
DESCRIPTIONWO2004103995
DESCRIPTIONWO2009095372
DESCRIPTIONWO2009122285
DESCRIPTIONWO2010048582
DESCRIPTIONWO2011092234
DESCRIPTIONWO2013006656
DESCRIPTIONWO2013027191
DESCRIPTIONWO2013111110
DESCRIPTIONWO2014081702
DESCRIPTIONWO2014095773
DESCRIPTIONWO2015006728
DESCRIPTIONWO2015013165
DESCRIPTIONWO2015013167
DESCRIPTIONWO2015013168
DESCRIPTIONWO2015013169
INTERNATIONAL-SEARCH-REPORTWO2014083505
INTERNATIONAL-SEARCH-REPORTWO2015006728
INTERNATIONAL-SEARCH-REPORTWO2015013168
INTERNATIONAL-SEARCH-REPORTWO2015013169
OPPOSITIONEP0492628
OPPOSITIONUS4517105
OPPOSITIONUS4582927
OPPOSITIONUS5175191
OPPOSITIONWO0102343
OPPOSITIONWO2011085000
OPPOSITIONWO2013113008
OPPOSITIONWO2013148117
OPPOSITIONWO2014120619
OPPOSITIONWO2015006728
OPPOSITIONWO2015013168
OPPOSITIONWO2015013169
OPPOSITIONWO8304412

Non-Patent Literature (NPL) Citations (11) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Chae, S.Y. ; Choi, Y.G. ; Son, S. ; Jung, S.Y. ; Lee, D.S. ; Lee, K.C., "The fatty acid conjugated exendin-4 analogs for type 2 antidiabetic therapeutics", Journal of Controlled Release, AMSTERDAM, NL , (20100521), vol. 144, no. 1, ISSN 0168-3659, pages 10 - 16, XP027036550
OPPOSITION- Olof Ceder, Waisvisz, J. M.; Van Der Hoeven, M. G.; Ryhage, R., "Pimaricin. II. High Pressure---High Temperature Hydrogenation Studies.", Acta Chemica Scandinavica, (19640101), vol. 18, pages 83 - 97, XP055223487
OPPOSITION- Swanson Ronald V., "Long Live Peptides - Evolution of peptide half-life extension technologies and emerging hybrid approaches ", Drug Discovery World (DDW), (20140421), URL: https://www.ddw-online.com/long-live-peptides-evolution-of-peptide-half-life-extension-technologies-and-emerging-hybrid-approaches-892-201404/, XP055963982
OPPOSITION- Strittmatter Harald, Hildbrand Stefan, Pollak Peter, "Malonic Acid and Derivatives", Ullmann's Encyclopedia of Industrial Chemistry, (20120101), pages 157 - 174, doi:10.1002/14356007.a16_063.pub2, XP055963986
OPPOSITION- Michael J. Hackett, Shyamsunder Joolakanti, Megan E. Hartranft, Patrick C. Guley, Moo J. Cho, "A dicarboxylic fatty acid derivative of paclitaxel for albumin-assisted drug delivery", Journal of Pharmaceutical Sciences, US , (20120901), vol. 101, no. 9, doi:10.1002/jps.23213, ISSN 0022-3549, pages 3292 - 3304, XP055223401
OPPOSITION- D. Lefort, Vorob'ev V. D., Somov G. V., Nikishin G. I., "Free-radical addition of alcohols and acids to 10-undecenoic esters, 10-undecen-1-Ol, and 10-undecenyl acetate", BULLETIN OF THE ACADEMY OF SCIENCES OF THE USSR, US , (19670301), vol. 16, no. 3, doi:10.1007/BF00906006, ISSN 0568-5230, pages 623 - 627, XP055223363
OPPOSITION- Lim Sung In; Mizuta Yukina; Takasu Akinori; Hahn Young S.; Kim Yong Hwan; Kwon Inchan, "Site-specific fatty acid-conjugation to prolong protein half-lifein vivo", Journal of Controlled Release, AMSTERDAM, NL , (20130602), vol. 170, no. 2, doi:10.1016/j.jconrel.2013.05.023, ISSN 0168-3659, pages 219 - 225, XP028676591
OPPOSITION- Wang, Q. Graham, K. Schauer, T. Fietz, T. Mohammed, A. Liu, X. Hoffend, J. Haberkorn, U. Eisenhut, M. Mier, W., "Pharmacological properties of hydrophilic and lipophilic derivatives of octreotate", Nuclear Medicine and Biology, US , (20040101), vol. 31, no. 1, doi:10.1016/S0969-8051(03)00099-4, ISSN 0969-8051, pages 21 - 30, XP004485708
OPPOSITION- Klein J., Gurfinkel E., "Metalation reactions. III. Metalation of octadecynols and octadecynyl methyl ethers", The Journal of Organic Chemistry, (19691201), vol. 34, no. 12, doi:10.1021/jo01264a044, pages 3952 - 3958, XP055964076
OPPOSITION- Fung Ella, Kang Liya, Sapashnik Diana, Benard Susan, Sievers Annette, Liu Yan, Yan Guoying, Zhou Jing, Rodriguez Linette, Ma Weijun, Stochaj Wayne R., Lavallie Edward, Wroblewska Liliana, Kelleher Kerry, Tam Amy, Bezy Olivier, Breen Danna, Chabot Jeffrey R., He Tao, Lin Laura, Wu Zhidan, Mosyak Lidia, "Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulation", Scientific Reports, (20211201), vol. 11, no. 1, doi:10.1038/s41598-021-87959-5, XP055964077
OPPOSITION- L. Zhang, G. Bulaj, "Converting Peptides into Drug Leads by Lipidation", Current medicinal chemistry, NL , (20120301), vol. 19, no. 11, doi:10.2174/092986712799945003, ISSN 0929-8673, pages 1602 - 1618, XP055300411

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents